These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8687481)

  • 1. Arylacetamide deacetylase activity towards monoacetyldapsone. Species comparison, factors that influence activity, and comparison with 2-acetylaminofluorene and p-nitrophenyl acetate hydrolysis.
    Preuss CV; Svensson CK
    Biochem Pharmacol; 1996 Jun; 51(12):1661-8. PubMed ID: 8687481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of dapsone and monoacetyldapsone in rats.
    Gordon GR; Peters JH; Ghoul DC; Murray JF; Levy L; Biggs JT
    Proc Soc Exp Biol Med; 1975 Nov; 150(2):485-92. PubMed ID: 1208566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The essential role of microsomal deacetylase activity in the metabolic activation, DNA-(deoxyguanosin-8-yl)-2-aminofluorene adduct formation and initiation of liver tumors by N-hydroxy-2-acetylaminofluorene in the livers of infant male B6C3F1 mice.
    Lai CC; Miller EC; Miller JA; Liem A
    Carcinogenesis; 1988 Jul; 9(7):1295-302. PubMed ID: 3383346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymic deacetylation of carcinogenic arylacetamides by tissue microsomes of the dog and other species.
    Lower GM; Bryan GT
    J Toxicol Environ Health; 1976 Jan; 1(3):421-32. PubMed ID: 1550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species specificity affects the choice of S9 preparations for use in the hamster embryo cell transformation system.
    Poiley JA; Raineri R
    In Vitro; 1984 Aug; 20(8):602-6. PubMed ID: 6500598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylation polymorphism of dapsone in a Japanese population.
    Horai Y; Ishizaki T
    Br J Clin Pharmacol; 1988 Apr; 25(4):487-94. PubMed ID: 3382590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis.
    Watanabe A; Fukami T; Nakajima M; Takamiya M; Aoki Y; Yokoi T
    Drug Metab Dispos; 2009 Jul; 37(7):1513-20. PubMed ID: 19339378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of eprinomectin N-deacetylase in rats.
    Zeng Z; Andrew NW
    Drug Metab Dispos; 1999 Feb; 27(2):269-73. PubMed ID: 9929515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
    Irshaid Y; Adedoyin A; Lotze M; Branch RA
    Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic modeling of beta-chloroprene metabolism: I. In vitro rates in liver and lung tissue fractions from mice, rats, hamsters, and humans.
    Himmelstein MW; Carpenter SC; Hinderliter PM
    Toxicol Sci; 2004 May; 79(1):18-27. PubMed ID: 14976339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of proguanil on the pharmacokinetics of dapsone in healthy volunteers.
    Edstein MD; Rieckmann KH
    Chemotherapy; 1993; 39(4):235-41. PubMed ID: 8325124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of N- and C-hydroxylations of 2-acetylaminofluorene in male Sprague-Dawley rat liver microsomes: implications for carcinogenesis.
    McManus ME; Minchin RF; Sanderson N; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1983 Aug; 43(8):3720-4. PubMed ID: 6861141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
    Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK
    J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of rat hepatic microsomal N,O-acyltransferases.
    Wang CY; Zukowski K; Lee MS; Sone T
    Carcinogenesis; 1992 Nov; 13(11):2017-20. PubMed ID: 1423870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Human Arylacetamide Deacetylase (AADAC) on Hydrolysis of Eslicarbazepine Acetate and Effects of
    Hirosawa K; Fukami T; Tashiro K; Sakai Y; Kisui F; Nakano M; Nakajima M
    Drug Metab Dispos; 2021 Apr; 49(4):322-329. PubMed ID: 33446525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
    Wroblewski VJ; Gessner T; Olson JR
    Biochem Pharmacol; 1988 Apr; 37(8):1509-17. PubMed ID: 3358781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition of dapsone and monoacetyldapsone in the dog (38516).
    Peters JH; Gordon R; Biggs JT; Levy L
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):251-5. PubMed ID: 1129265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic observations on dapsone in dermatitis herpetiformis.
    Swain AF; Ahmad RA; Rogers HJ; Leonard JN; Fry L
    Br J Dermatol; 1983 Jan; 108(1):91-8. PubMed ID: 6821646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N- and O-deacetylation of N-acetoxy-N-arylacetamides by mammalian hepatic microsomes.
    Yamada H; Lee MS; Wang CY
    Carcinogenesis; 1988 Nov; 9(11):1995-2002. PubMed ID: 3180338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.